SECsense Logo

Moderna, Inc. 8-K Filing Report: Key Insights for Investors

$MRNA
Form 8-K
Filed on: 2025-01-13
Source
Moderna, Inc. 8-K Filing Report: Key Insights for Investors

From the provided XML section of a financial report, here are the key pieces of information extracted:

  1. Company Information:
  • Name: Moderna, Inc.
  • CIK: 0001682852
  • Institution Type: Publicly traded company (Common stock).
  • Par Value: $0.0001 per share.
  • Ticker Symbol: MRNA (listed on NASDAQ).
  1. Address:
  • Headquarters: 325 Binney Street, Cambridge, MA 02142
  • Phone: 617-714-6500
  1. Filing Details:
  • Form Type: 8-K
  • Filing Date: January 13, 2025
  1. Time Period Covered:
  • Start Date: January 13, 2025
  • End Date: January 13, 2025
  1. Filing Context:
  • This filing is under the XBRL format, which indicates it is structured for data analysis and interoperability.

Insights:

  • The report is an 8-K, which typically indicates a significant event or development that shareholders should be aware of.
  • The specified date (January 13, 2025) suggests this filing may be related to a recent corporate event or announcement.
  • The company is publicly traded and operates in the biotech sector, which could imply volatility and market responsiveness, especially given the nature of their business.

This information is crucial for investors, analysts, and stakeholders looking to understand Moderna's current standing and any potential implications of the reported events.